Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.579
-0.072 (-11.00%)
At close: Nov 4, 2024, 4:00 PM
0.595
+0.016 (2.78%)
Pre-market: Nov 5, 2024, 5:21 AM EST

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
83511418,67315,354
Market Cap Growth
66.15%-30.67%-95.78%-99.39%21.62%-
Enterprise Value
72911218,676-
Last Close Price
0.581.069.001128.002984.332500.80
PE Ratio
--0.23-0.06-3.173552.78-247.00
PS Ratio
2.111.501.9132.284750.028704.12
PB Ratio
2.61-5.12-1.19-13.97-2804.47-2299.75
P/FCF Ratio
-0.39-0.31-0.27-13.83-14970.49-16416.48
P/OCF Ratio
-0.39-0.31-0.27-13.83-14970.49-16416.48
EV/Sales Ratio
4.940.853.5531.674750.60-
EV/EBITDA Ratio
---0.37-5.63-11577.56-
EV/EBIT Ratio
-0.04-0.18-0.37-5.63-11576.12-
EV/FCF Ratio
-0.04-0.18-0.50-13.57-14972.32-
Debt / Equity Ratio
0.31-1.31-1.10-2.11-0.64-0.39
Debt / FCF Ratio
-0.05-0.08-0.25-2.09-3.42-2.80
Asset Turnover
0.310.520.230.428.06-
Quick Ratio
0.970.370.360.770.030.07
Current Ratio
1.880.690.560.950.050.08
Return on Assets (ROA)
-131.94%-155.91%-135.76%-148.12%-206.67%-
Return on Capital (ROIC)
-195.31%-2204.12%-320.05%-372.49%--
Earnings Yield
-140.56%-318.25%-502.54%-25.51%0.00%-0.07%
FCF Yield
-121.92%-323.25%-371.88%-7.23%-0.01%-0.01%
Buyback Yield / Dilution
-452.78%-1158.34%-114.15%-22.15%93.11%-
Total Shareholder Return
-452.78%-1158.34%-114.15%-22.15%93.11%-
Source: S&P Capital IQ. Standard template. Financial Sources.